124 related articles for article (PubMed ID: 37133510)
1. False-Positive Radioactive Iodine Uptake Caused by Cervical Myofascitis in a Patient With Differentiated Thyroid Carcinoma.
Tan X; Wang H; Deng Y; He L; Zhang W
Clin Nucl Med; 2023 Jun; 48(6):512-514. PubMed ID: 37133510
[TBL] [Abstract][Full Text] [Related]
2. False-Positive 131I Uptake After Transareola Endoscopic Thyroidectomy in a Patient With Papillary Thyroid Carcinoma.
Wang A; Fu W; Deng Y; He L; Zhang W
Clin Nucl Med; 2022 Apr; 47(4):324-325. PubMed ID: 35025806
[TBL] [Abstract][Full Text] [Related]
3. [Impact of 131I SPECT/CT on the management of differentiated thyroid carcinoma outpatients with radioablation].
Mizokami D; Kosuda S; Shiotani A; Kinoshita F; Saotome K; Morozumi K
Nihon Jibiinkoka Gakkai Kaiho; 2014 May; 117(5):673-80. PubMed ID: 24956745
[TBL] [Abstract][Full Text] [Related]
4. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
5. Unexpected radioactive iodine accumulation on whole-body scan after I-131 ablation therapy for differentiated thyroid cancer.
Iwano S; Ito S; Kamiya S; Ito R; Kato K; Naganawa S
Nagoya J Med Sci; 2020 May; 82(2):205-215. PubMed ID: 32581401
[TBL] [Abstract][Full Text] [Related]
6. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
[TBL] [Abstract][Full Text] [Related]
7. An Unusual False-Positive Uptake of Radioiodine Caused by Breast Implants.
Wang Y; Jiang L; Xu Y; Zhang X; Liu B
Clin Nucl Med; 2022 Jul; 47(7):646-647. PubMed ID: 35353751
[TBL] [Abstract][Full Text] [Related]
8. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
Rubello D; Mazzarotto R; Casara D
Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
[TBL] [Abstract][Full Text] [Related]
9. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
Salvatori M; Perotti G; Rufini V; Maussier ML; Dottorini M
Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184
[TBL] [Abstract][Full Text] [Related]
10. False-Positive Uptake of 131I Due to Tubal Ligation in a Patient With Papillary Thyroid Cancer.
Tong J; Jin Y; Liu M; Lv Z; Chen L
Clin Nucl Med; 2018 May; 43(5):375-376. PubMed ID: 29517545
[TBL] [Abstract][Full Text] [Related]
11. Unexpected Retrosternal Goiter Interpreted as Hyperfunctioning Metastasis on the Posttherapeutic 131I SPECT/CT.
Hou LY; Luo QY; Qiu ZL
Clin Nucl Med; 2022 Mar; 47(3):258-259. PubMed ID: 34661561
[TBL] [Abstract][Full Text] [Related]
12. Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a
Spanu A; Nuvoli S; Marongiu A; Gelo I; Mele L; Piras B; Madeddu G
BMC Cancer; 2020 Mar; 20(1):239. PubMed ID: 32197595
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer.
Shankar LK; Yamamoto AJ; Alavi A; Mandel SJ
J Nucl Med; 2002 Jan; 43(1):72-6. PubMed ID: 11801706
[TBL] [Abstract][Full Text] [Related]
14. Incidental thyroid 99mTc-MDP uptake in a patient affected by differentiated thyroid cancer.
Albano D; Magri GC; Treglia G; Bertagna F
Nucl Med Rev Cent East Eur; 2016; 19(B):8-10. PubMed ID: 27813621
[TBL] [Abstract][Full Text] [Related]
15. Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy.
de Klerk JM; de Keizer B; Zelissen PM; Lips CM; Koppeschaar HP
Nucl Med Commun; 2000 Jun; 21(6):529-32. PubMed ID: 10894561
[TBL] [Abstract][Full Text] [Related]
16. 131I uptake in intraosseous hemangioma of the skull: mimicking a bone metastasis in thyroid cancer.
Lee M; Lee YK; Jeon TJ; Park CS; Ryu YH
Clin Nucl Med; 2014 Nov; 39(11):990-2. PubMed ID: 24978336
[TBL] [Abstract][Full Text] [Related]
17. Variable 131I Activity in Renal Stone in a Patient With Thyroid Cancer.
Liu S; Chen L; Zhang D; Cao C; Shao F
Clin Nucl Med; 2021 Apr; 46(4):332-334. PubMed ID: 33492857
[TBL] [Abstract][Full Text] [Related]
18. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.
Lorberboym M; Murthy S; Mechanick JI; Bergman D; Morris JC; Kim CK
J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199
[TBL] [Abstract][Full Text] [Related]
19. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of preoperative radioactive iodine (131I) therapy for locally advanced papillary thyroid cancer: a case report.
Shingu K; Kobayashi S; Yokoyama S; Shimizu T; Kasuga Y; Fujimori M; Ito K; Hama Y; Amano J
Thyroid; 1998 Dec; 8(12):1113-6. PubMed ID: 9920366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
